Neimeth International Pharmaceuticals Plc reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NGN 488.62 million compared to NGN 708.96 million a year ago. Net loss was NGN 263.05 million compared to net income of NGN 307.43 million a year ago. Basic loss per share from continuing operations was NGN 0.06 compared to basic earnings per share from continuing operations of NGN 0.16 a year ago.
For the six months, sales was NGN 957.4 million compared to NGN 1,634.75 million a year ago. Net loss was NGN 452.56 million compared to net income of NGN 175.46 million a year ago. Basic loss per share from continuing operations was NGN 0.11 compared to basic earnings per share from continuing operations of NGN 0.0924 a year ago.